Based on 2024–2025 ADA/EASD guidelines, Joint British Diabetes Societies protocols, NICE/SIGN updates, and Surviving Sepsis Campaign recommendations.
| Domain | Key Principles | Integration Points |
|---|---|---|
| Preoperative Optimization | HbA1c threshold >8.5% — consider delay; medication reconciliation (SGLT2i hold 3–4 days) | Pharmacology Assessment Shared Decision-Making |
| Intraoperative Management | Target 140–180 mg/dL; VRIII for NBM patients; hourly monitoring | NICE-SUGAR Insulin Titration Vigilance |
| DKA/HHS Emergencies | Fluid resuscitation, insulin therapy, K⁺ replacement, treat precipitant | Pathophysiology Protocol Execution Crisis Leadership |
| Hypoglycaemia Prevention | Background glucose infusion for NBM; recognise high-risk patients | Risk Factors Rescue Protocol Speaking Up |